Did you know our first-in-class antiviral drug-Fc conjugate (DFC) candidate has demonstrated universal activity across #influenza A and B viruses, including potent activity against #H5N1 in preclinical studies? Read more here: https://bit.ly/3XgCzXA
Congratulations Cidara team. This new drug-Fc conjugate format is a new class of therapy with potential for being transformative in infectious disease, cancer and autoimmune indications !!
Chief Evangelist & Anti-PR Strategist… A Results-Ravenous Renegade: Master of Disruption!
2mo👏 Impressive progress in antiviral research! Excited to see advancements in combating influenza viruses. 🦠